Yuanbao Inc (NAS:YB)
$ 13.59 -0.13 (-0.91%) Market Cap: 626.23 Mil Enterprise Value: -50.48 Mil PE Ratio: 3.29 PB Ratio: 1.15 GF Score: 22/100

Q3 2025 Yuanbao Inc Earnings Call Transcript

Dec 03, 2025 / 12:00PM GMT
Release Date Price: $22.73 (+10.07%)

Key Points

Positve
  • Yuanbao Inc (YB) reported a 33.6% year-over-year increase in total revenues, reaching RMB1.16 billion.
  • Net income surged by 51.3% year-over-year, marking the 13th consecutive quarter of profitability.
  • The company has a strong cash reserve of RMB3.75 billion, providing a solid financial foundation for future growth.
  • Yuanbao Inc (YB) has enhanced AI and data capabilities, improving consumer targeting and product innovation.
  • The company launched a novel critical illness insurance product with high coverage at an affordable price, showcasing innovation in product offerings.
Negative
  • Operating expenses increased by 31.2% year-over-year, driven by higher selling, marketing, and R&D expenses.
  • G&A expenses rose significantly by 97.8% year-over-year due to higher personnel costs.
  • The competitive landscape remains challenging with potential impacts from new tax regulations affecting advertising costs.
  • There is a need to balance growth with profitability as the market for commercial health insurance expands.
  • The company faces competition from ecosystem players, requiring continuous innovation to maintain its competitive edge.
Operator

Ladies and gentlemen, good day and welcome to Yuanbao Inc., third-quarter 2025 earnings conference call. Today's conference is being recorded.

At this time, I'd like to turn the conference over to Ms. Stella Liu, Investor Relations and Strategy Associate Director. Please go ahead.

Stella Liu
Yuanbao Inc - Investor Relations and Strategy Associate Director

Thank you, operator. Please note that today's discussion will contain forward-looking statements made under the Safe Harbor provisions of the US Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to certain risks and uncertainties, assumptions and other factors. Some of these risks are beyond the company's control and could cause actual results to differ materially from those mentioned in today's press release and discussion.

A general discussion of the risk factors that could affect Yuanbao's business and financial results is included in certain filings of the company with the Securities and Exchange Commission. The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot